Newsletters & Blog

Many of you have asked about Helen Blau’s work at Stanford, using telomerase mRNA [FASEB Journal]. Helen sent me a copy of her article when it came out and I’m a serious fan of her work. As some of you know from my upcoming book, The Telomerase Revolution, there are four approaches to resetting telomeres: […]

My new book, The Telomerase Revolution, is now finished and is being copy edited by the publisher. Oddly enough, it’s already selling well in preorders. Amazon.com says that it is now the “#1 release in medical research”, which is a delightful surprise, since it won’t actually be published and available to the public until October. […]

A friend pointed out that a recent Danish study suggested that short telomere lengths in circulating peripheral lymphocytes account for about a quarter of the variance in mortality. Does this mean that lymphocyte telomere lengths (LTL’s) are really only a minor factor in age-related disease and mortality? Probably, but it’s not the important question. A […]

Things are slowly beginning to move ahead on our project to cure Alzheimer’s disease. It’s clear that not only is the role of microglia slowly becoming accepted, but there are more and more investors who see an opportunity to help move biotech and medicine from the old paradigm (BAPP and Tau cause disease) to the […]

An odd thing is happening in the world of biotechnology: an avalanche is starting. The context is also interesting, for over the past twenty five years, a profound revolution has occurred in our understanding of aging. Where once we took aging for granted, we now reexamine the process, looking for a way to reverse it. […]

Every several weeks, I notice publication of yet another article trumpeting another aspect of Alzheimer’s. Where once it was APOE-4, AB42, or SS31 (an antioxidant peptide), more recent work emphasizes arginine metabolism in the microglia. The good news is that research community has — ponderously and hesitantly — finally begun to shift the clinical focus […]

At the moment, there are four companies planning human trials to reset telomeres using telomerase genes. In every case, the intent is to put the telomerase genes (hTERT and hTERC) into human patients in an effort to cure age-related diseases. Let’s look at the diseases and then the companies involved. Essentially, all age-related diseases occur […]

As I write this in March of 2015, there are 1,315 registered clinical studies of potential interventions for Alzheimer’s disease (see ClinicalTrials.gov). While it is hard to define clearly, many of these studies deal with nursing issues, rather than medical interventions aimed at preventing or curing the pathology itself. Of those that are testing potential […]

What is aging? There are literally dozens of answers to that question, even if we restrict ourselves to purely academic views. In the days when I was the executive director of the American Aging Association, there were – or so it seemed – as many aging hypotheses as we had members of the association. Almost […]

Most of us assume that aging equals illness. To be honest about it, we don’t usually put it that bluntly and we often deny it, even to ourselves, and yet we tend to assume that unless we are struck down suddenly – an unexpected automobile accident, a sudden pneumonia, a fatal heart attack – we […]

Telomerase does not cause cancer. The statement is accurate, but it’s not that simple nor is it a naïve concern. Telomerase and cancer are clearly linked – telomerase has been called “the two-edged sword” with aging being one edge and cancer the other – and the question thus deserves a more complete and more sophisticated […]

As of 2013, we can neither cure nor prevent a single age-related disease. Even at our absolute best – and then only questionably and in one or two cases – can we even slow the unrelenting progress of any of our myriad age-related diseases. Trying for an optimistic view of current medical interventions, and even […]

The notion that telomeres play a central role in both age-related disease and aging itself is generally misunderstood and is often criticized without an actual understanding of either disease or telomeres, yet there is a growing sense of the obvious about the role of telomeres in human aging and disease. More and more people – […]

Reversing Human Aging was the first book in history to describe how aging works, how to reverse it, and the consequences of doing so. Originally published in 1996, it has largely passed the test of time. On October 1st, I published an electronic edition of this book on Amazon.com and made it available for those […]

What is aging? The question has always been hard to answer, making it difficult to change the process, let alone to reverse its clinical progress. Unfortunately, much of the problem derives from the way we look at aging in the first place. Making the wrong assumptions, we arrive at the wrong conclusions. While human beings […]